proliferating tissues such as the spleen and testis, sug-
gesting the possibility that KIF13A is more important in of the KIFs that is phylogenetically distant from KIFs functioning in cell division. intracellular transport than in mitotic cell division. Second, the molecule is evolutionarily conserved from C.
The full-length cDNA of KIF13A was cloned. KIF13A consists of 1749 amino acids with its motor domain elegans to mammals. Third, KIF13A is a new member (E) Yeast two-hybrid assay. Eight different deletion constructs of ␤1-adaptin were tested for their interaction ability with KIF13A. The number in the bracket of each deletion mutant indicates the amino acid number of ␤1-adaptin. KIF13A and ␤1-adaptin deletion constructs were cotransformed into yeasts. The transformants were plated onto SC plates (lacking luecine, tryptophane, and uracil) and X-gal plates (lacking histidine, tryptophane, uracil, and leucine). (F) Proteins in the brain lysate that were bound to the GST-CTF2 column were eluted with reduced glutathione. Elution fractions (lanes 2-6) were resolved by SDS-PAGE, and Western blotting was performed using antibodies against subunits of the AP-1 complex (anti-␤1,2-adaptin, anti-␥-adaptin, and anti-1-adaptin antibodies). In lane 1, the input brain lysate applied onto the column was Western blotted with an anti-␤1,2-adaptin antibody. In the input, ␤2-adaptin was more abundant than ␤1-adaptin. In the elution fraction, ␤1-adaptin was specifically eluted. Moreover, subunits of the AP-1 complex coeluted from the column. (G) The peak elution fraction in F (described as purified ␤-1 and purified -1 in the figure) was further fractionated by 5%-30% (wt/vol) linear sucrose velocity gradient centrifugation. To compare the S values with native AP-1 in the brain lysate, brain-high-speed supernatant was also fractionated. Purified ␤1-adaptin (the band that was peptide-sequenced) was detected by CBB staining. Other subunits were detected by Western blotting. Purified AP-1 complex and native AP-1 formed different peaks. The positions of marker proteins are indicated above. 4.3S (BSA), 11.1S (catalase), and 16.5S (thyroglobulin). (H) Densitometric analysis of sucrose velocity gradient centrifugation. Native AP-1 in brain lysate was 7.7S, whereas purified AP-1 was 8.9S. The difference in the S values can be explained because the KIF13A tail domain (GST-CTF2) is bound to the purified AP-1 in the column eluate. (I) KIF13A binds to the ear domain of ␤1-adaptin. To determine the specificity of binding, a GST pull-down experiment was performed in the brain lysate using ear domains of ␤1-and ␤2-adaptin as probes. GST was used as a control probe. Brain lysate was incubated with an equal amount of probes (GST, GST␤1-ear domain, and GST␤2-ear domain). Proteins bound to each probe were resolved by SDS-PAGE and Western blotted using an anti-KIF13A antibody. The CBB staining result of the applied probes is shown in the lower panel. in the amino terminal ( Figure 1A ). An AF6/cno domain tubules in the presence of 0.5 mM AMP-PNP. When the microtubules were ultracentrifuged, most of KIF5B (the (Ponting, 1995) exists, which is also observed in KIF1 family members. The function of this domain is unknown.
conventional kinesin) was absorbed to the microtubules and the pellet (lane 2), while KIF13A was equally distribNo other domains were detected by the motif search. The full sequence is available in GenBank (accession uted in the pellet and supernatant (lanes 1 and 2). On incubating the resuspended microtubules pellet in 5 mM #AB037923). The homology between KIF13A and KIF1A (the most related KIF by molecular phylogenetic analy-ATP, ATP-dependent release of KIF13A was observed (lanes 3 and 4). KIF5B and tubulin were monitored as sis) is plotted in Figure 1B . The putative cargo binding domain at the carboxyl terminal is different between the experimental controls. Motor activity was assayed by differential interference two molecules. Recombinant KIF13A ( Figure 1C ) and synthetic peptides were used to generate polyclonal contrast microscopy and video system. KIF13A was a fast plus-end directed microtubule-dependent molecuantibodies in rabbits. The KIF13A antibody recognized a 200 kDa protein in the brain lysate by Western blotting lar motor, and could slide axonemes in a microtubule minus-end direction ( Figure 1K ). The average velocity (calculated molecular weight ϭ 195.8 kDa). Both KIF13A mRNA (Nakagawa et al., 1997) and the protein were was 0.1-0.3 m/s, which indicates that KIF13A can function as a motor for fast intracellular transport. observed to be ubiquitously distributed in tissues (Figure 1D) . A weak cross-reactivity at 116 kDa was detected Altogether, KIF13A has the characteristics of a vesicle-transporting microtubule-dependent motor protein. in the testis and PC12 cell. The identity of this 116 kDa protein was not determined. KIF13A was also expressed in most subregions of the nervous system ( Figure 1E ).
Tail Domain of KIF13A Forms a Complex with ␤1-Adaptin KIF13A was recovered from both the soluble and the membrane fractions by differential centrifuge cell fracThe nonmotor domain of KIF13A (the tail domain) is expected to bind to a specific cargo. To identify proteins tionation ( Figure 1F ). Brain lysates were fractionated by a Nycodenz density gradient flotation assay to confirm binding to KIF13A from the mouse brain, the tail domain of KIF13A fused to GST was immobilized to a column the existence of KIF13A on vesicles ( Figure 1G ). KIF13A was detected as two peaks, a soluble peak and a vesito perform affinity chromatography. Two GST fusion constructs, GST-CTF1 and GST-CTF2 (Figure 2A ), were cle-bound peak. When the lysate was treated with NP-40 before being subjected to the Nycodenz density gradiused. The 110 kDa band (p110) was specifically copurified with GST-CTF2 beads, not with GST-CTF1 beads ent assay, the vesicle-bound KIF13A peak disappeared. This suggests that KIF13A is associated with NP-40 ( Figure 2B ). Amino acid sequencing revealed that p110 is ␤1-adaptin, a subunit of the AP-1 complex (Zaremba soluble vesicles.
To To identify the binding domain of ␤1-adaptin with AP-1 Complex Is Copurified with KIF13A Tail Domain KIF13A tail domain, we used the yeast two-hybrid interaction assay ( Figure 2E ). Only the full-length ␤1-adaptin ␤1-adaptin is a subunit of the tetrameric protein complex, AP-1 (major ␤1 and ␥ subunits, and minor 1 and and fusion proteins that contained the ear domain interacted with the KIF13A tail domain. Thus, the ear domain 1 subunits). In TGN, AP-1 binds to clathrin to enhance the clathrin-coat assembly at the newly formed clathrinof ␤1-adaptin is responsible for the interaction with KIF13A.
coated buds. AP-1 interacts with the cytoplasmic do-main of the membrane proteins and recruits them to the CTR433 and polyclonal antibody against rab6 (Martinez et al., 1994) ( Figures 3G-3I ). The intracellular localization newly formed clathrin-coated buds. We further determined whether KIF13A can bind to ␤1-adaptin in the of KIF13A was further determined by immunoelectron microscopy. The KIF13A was specifically detected on form of the AP-1 complex.
The eluate from the GST-CTF2 column was examined, membranes, particularly on the Golgi apparatus and vesicles ( Figure 3K ). The ultrastructural subcellular loin detail, by Western blotting with other subunits of the AP-1. Both ␥-adaptin and 1-adaptin were coeluted with calization of KIF13A is consistent with its biochemical interaction with AP-1. ␤1-adaptin ( Figure 2F ). The peak fraction was further fractionated by sucrose velocity gradient centrifugation ( Figure 2G ). ␤1-, ␥-, and 1-adaptin existed in the same KIF13A Tail Domain Purifies Clathrin-Coat-Negative fractions, supporting that these proteins form a com-AP-1-Containing Vesicles plex. The size of the complex was determined to be 8.9
The vesicle fractions of the Nycodenz density gradient S by sucrose velocity gradient centrifugation ( Figure 2H The authenticity of the isolated vesicles was confirmed brane, whereas AP-2 functions in vesicle trafficking from by the immuno-EM observation, which detects KIF13A the plasma membrane to the endosomes (Pearse, 1988) .
antigens on vesicles that are similar in size ( Figure 3K ).
In most cells, the polarity of radiating microtubules is
We evaluated if AP-1 actually exists on vesicles that such that the minus-ends are directed toward the MTOC can bind KIF13A. Vesicles were affinity-purified with the where the Golgi apparatus exists and the plus-ends are KIF13A tail domain attached to a solid support (cover directed toward the cell periphery. AP-1 should be on glass) and further visualized by immunofluorescence mithe vesicles that move toward the plus-ends, and AP-2 croscopy (vesicle tethering assay on cover glass). toward the minus-ends. Thus, it is likely that AP-2 and
The presence of AP-1 on the vesicles isolated by AP-1 are associated with different motors.
KIF13A tail was visualized by staining the tethered vesiWe determined whether KIF13A interacts only with cles on the cover glass with an anti-AP-1 monoclonal AP-1 or with both AP-1 and AP-2. The KIF13A tail domain antibody ( Figures 3R-3W ). Approximately 40% of the copurifies more ␤1-adaptin than ␤2-adaptin from the vesicles that were specifically tethered by the KIF13A brain lysate ( Figure 2F ). When GST pull-down was pertail domain were AP-1 positive, whereas less than 10% formed with GST (control), the GST-␤1-adaptin ear doof the vesicles that were tethered by control protein main, and the GST-␤2-adaptin ear domain as probes, (CTF1 fragment) were AP-1 positive ( Figure 3T ). KIF13A was copurified more with the ␤1-adaptin ear Thus, AP-1 is present but the clathrin coat is absent domain than with the ␤2-adaptin ear domain ( Figure 2I ). on vesicles that can bind to the KIF13A tail domain. This Thus, KIF13A binds to ␤1-adaptin with higher affinity suggests that clathrin-coated vesicles formed in TGN are than to ␤2 in vitro. uncoated during KIF13A-dependent vesicle transport. (Figures 6G-6I) . None of these control exper-M6PR. iments mistargeted M6PR (Figures 6A-6I) .
Subcellular

M6PR staining of MDCKII cells transfected with KIF13A (A and D). In some cases accumulation of M6PR, together with KIF13A, was observed at the cell periphery (A, B, and C). (C) is a merge of (A) and (B), (F) is a merge of (D) and (E). Note that perinuclear staining of M6PR disappears in cells overexpressing KIF13A (C and F). KIF13A overexpressing cells are highlighted in (B) and (E). Only one cell is observed to overexpress KIF13A in (B) and (E). The arrows indicate the processes extending from
None of the membrane compartments were disorganized by overexpressing KIF13A (Figures 4G-4R) . Thus, Discussion overexpression of KIF13A specifically redistributes AP-1 and M6PR, suggesting that both AP-1 and M6PR are AP-1 Is a Motor Adaptor as well as a Coat Adaptor transported by KIF13A.
We identified a novel motor KIF13A that interacts directly with the ␤1 subunit of a general adaptor, AP-1. Our study demonstrates the molecular mechanism by Functional Blockade of KIF13A by Dominant Negative Protein Reduces M6PR Expression which KIF interacts with the membrane. The function of AP-1 is to bind to the transmembrane receptors (for Levels on the Cell Surface AP-1 functions in protein targeting from the TGN to the example, mannose-6-phosphate receptor) (Pearse, 1988) and enhance recruitment of clathrin coat to induce forplasma membrane in MDCK cells (Folsch et al., 1999) 
